Average Co-Inventor Count = 5.60
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (5 from 4,179 patents)
2. Bayer Pharmaceuticals Corporation (5 from 70 patents)
3. The Institute for Pharmaceutical Discovery, LLC (4 from 13 patents)
4. Bayer Corporation (1 from 1,008 patents)
5. Bayer Healthcare LLC (1 from 780 patents)
6. Bayer Intellectual Property Gmbh (1 from 721 patents)
7. The Institutes for Pharmaceutical Discovery LLC (1 from 3 patents)
8. Alinea Pharmaceuticals, Inc. (1 from 1 patent)
9. The Institute for Dibetes Discovery LLC (1 from 1 patent)
10. Bayer Pharma Aktiengesellschaft (378 patents)
20 patents:
1. 8431695 - Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
2. 8163932 - Substituted indolealkanoic acids
3. 7928239 - Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
4. 7659269 - Substituted indolealkanoic acids
5. 7517880 - Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
6. 7371763 - Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
7. 7304079 - Substituted indolealkanoic acids
8. 7109196 - 1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
9. 7105514 - Substituted indolealkanoic acids
10. 6900205 - 1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders
11. 6784167 - 17-beta-hydroxysteroid dehydrogenase-II inhibitors
12. 6730794 - Substituted indolealkanoic acids
13. 6426344 - Aryl and heteroaryl substituted indolealkanoic acids
14. 6344476 - Inhibition of p38 kinase activity by aryl ureas
15. 6214991 - Substituted indolealkanoic acids